Kyoto University Innovation Capital — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
BTB Therapeutics, Inc.btbtherapeutics.cominJan 2025
BTB Therapeutics develops a non-opioid analgesic aimed at addressing the opioid crisis, along with a pipeline of RNA-modifying compounds for rare genetic diseases and to enhance cancer immunotherapy.
BiotechHealthtechMedical DevicesEscondido, US
Masatoshi Hagiwara(Chief Scientific Officer, Director of the Board (founder of BTB Therapeutics Co., Ltd.))Takashi Kiyoizumi(CEO, Director of the Board)inKenneth W. Locke(Chief Development Officer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.